NCT02213536|Terminated
Study Stopped
Poor recruitment and follow up
Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.
SPARE
Loading search results
Sponsor study identifier
observational
5
1 country
1
Study Start
August 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 20, 2019
Actual (reported)Study Completion
February 20, 2019
Actual (reported)To investigate the use of a scalp sparing technique of radiotherapy treatment designed to treat the whole brain. Current treatment methods to treat the whole brain with radiotherapy result in complete alopecia as a side effect. Hair loss is usually patchy and uneven and re-growth similar and slow. It is hoped that reducing the radiation dose to the hair bearing follicle on the scalp will reduce hair loss and increase the speed and evenness of re-growth.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 20, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 8, 2014
Actual (reported)August 11, 2014
Actual (reported)August 2015
Date type not reportedThis date has not been verified as actual or estimated.
February 20, 2019
Actual (reported)February 20, 2019
Actual (reported)To assess hair loss and hair regrowth in patients undergoing WBRT using VMAT via photographic assessment by independent professionals at intervals up to 16 weeks post end of treatment.
4 months post radiotherapy treatment
To assess patient perceptions of hair loss and hair regrowth in patients undergoing WBRT using VMAT via self assessment at intervals up to 16 weeks post end of treatment.
4 months post radiotherapy treatment end
Patients requiring whole brain radiotherapy as part of their cancer managment.
Delivering a prescribed radiation dose to the whole brain using VMAT to reduce dose to hair follicles on scalp.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients with a positive cancer diagnosis requiring whole brain radiotherapy with a life expectancy greater than 4 months.
The Harley Street Clinic
London, W1G 8PP, United Kingdom
David Landau, DR
Clinical Oncologist with practising privilages at The Harley Street Clinic, HCA International Limited hospitals.
5 participants (actual enrollment reported by the registry).
First Submitted
August 8, 2014
First Posted
August 11, 2014
Study Start
August 2015
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Primary Completion
February 20, 2019
Actual (reported)Study Completion
February 20, 2019
Actual (reported)Last Updated
February 22, 2019
Record last verified: 2019-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: